# Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

> **NCT00309712** · NA · COMPLETED · sponsor: **Intermountain Health Care, Inc.** · enrollment: 300 (—)

## Conditions studied

- Type II Diabetes Mellitus
- Mixed Dyslipidemia

## Interventions

- **DRUG:** fenofibrate 160 mg and placebo
- **DRUG:** simvastatin 20 mg and placebo
- **DRUG:** fenofibrate 160 mg and simvastatin 20 mg

## Key facts

- **NCT ID:** NCT00309712
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 300 (—)
- **Last updated:** 2008-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309712, "Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00309712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*